Document is current
Any future updates will be listed below
-
Authors
Vogelbacher, Christoph http://orcid.org/0000-0002-3191-1400
Sommer, Jens
Schuster, Verena
Bopp, Miriam H. A.
Falkenberg, Irina
Ritter, Philipp S.
Bermpohl, Felix
Hindi Attar, Catherine
Rauer, Lisa
Einenkel, Karolin E.
Treutlein, Jens
Gruber, Oliver
Juckel, Georg
Flasbeck, Vera
Mulert, Christoph
Hautzinger, Martin
Pfennig, Andrea
Matura, Silke
Reif, Andreas
Grotegerd, Dominik
Dannlowski, Udo
Kircher, Tilo
Bauer, Michael
Jansen, Andreas
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EE1404A-H, 01EE1404E)
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 17 March 2021
Accepted: 5 October 2021
First Online: 17 November 2021
Declarations
:
: Project A1 was approved by all local ethics committees and is registered with ExternalRef removed as NCT02456545. Project A2 was approved by all local ethics committees and is registered with ExternalRef removed as NCT02506322. Project B2 obtained ethics approval via the central ethics committee for pharmaceutical studies (BfArM). It is registered with ExternalRef removed as NCT02039479. All participants provided written informed consent after comprehensive information about study aims and procedures.
: Not applicable.
: AP has received speakers honoraria and travel support from Janssen and Lundbeck. CV, JS, VS, MHAB, IF, PSR, FB, CHA, LR, KEE, <i>JT</i>, OG, GJ, VF, CM, MH, AP, SM, AR, DG, UD, TK, MB, AJ did not state any conflict of interest.
